European Human Genetics Conference 2007 June 16 – 19, 2007 ...
European Human Genetics Conference 2007 June 16 – 19, 2007 ...
European Human Genetics Conference 2007 June 16 – 19, 2007 ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Prenatal diagnosis<br />
Netherlands.<br />
The detection of a skeletal dysplasia during pregnancy creates an intricate<br />
situation depending on the type of the skeletal dysplasia and the<br />
stage of the pregnancy. Establishing a diagnosis as exact as possible<br />
is important for support and management of the existing pregnancy<br />
and may have consequences for future pregnancies. Due to the time<br />
factor, a diagnosis is not always found during the on-going pregnancy.<br />
Additional information, such as follow-up after birth, skeletal X-rays,<br />
obduction and chromosomal and DNA-investigations is essential in<br />
such a situation. We present one postnatal and two prenatal cases<br />
of a rare skeletal dysplasia, where DNA-investigation confirmed the<br />
subtype of the skeletal dysplasia and generated important information<br />
about prognosis. In one prenatal case, MRI-examination of the<br />
pregnancy gave valuable additional information for the differential diagnosis.<br />
P0485. β-Thalassemia Carrier Screening and Prenatal Diagnosis<br />
among Iranian Population<br />
M. Sajedifar 1,2 , V. Lotfi 1,2 , P. Fouladi 1,2 , A. Joudaki 1 , F. Hashemi 1 , S. Zeinali 1,3 ;<br />
1 Medical <strong>Genetics</strong> Lab of Dr Zeinali, Tehran, Islamic Republic of Iran, 2 Young<br />
Researchers Club of research and science branch of Islamic Azad University,<br />
Tehran, Islamic Republic of Iran, 3 <strong>Human</strong> <strong>Genetics</strong> Unit, Dept of Biotech ,Pasteur<br />
Institute, Tehran, Islamic Republic of Iran.<br />
Thalassemia is one of the most common monogenic disease worldwide<br />
and also in Iran. More than 200 different mutations have been<br />
reported to date, and each ethnic population has it ‘ s own cluster of<br />
common mutations. This is well illustrated by the experience of the<br />
National Thalassemia Screening Program in Iran. Molecular analysis<br />
of β-globin mutations has been performed by PCR-based protocols<br />
(ARMS, RFLP, DNA Sequencing) mostly for prenatal diagnostic in our<br />
center.DNA samples are usually tested for mutations like IVS-II-I, IVS-<br />
I-5, IVS-I-110,codon 5, codon 17,codon 41/42(-TTCT) and many common<br />
mutations and deletions.<br />
In a population of <strong>19</strong>54 prenatal diagnosis (PNDs) performed since<br />
mid 2000 and we have found 24% normal, 50.7% β-Thalassemia carriers<br />
and 22.9% affected (β-Thalassemia major).<br />
Prenatal diagnosis has been an ongoing program in Iran since <strong>19</strong>96<br />
by a religious decree. Our center is part of the PND Network in Iran<br />
and the above PNDs have been performed as a part of the program to<br />
curtail β-thalassemia.<br />
Keyword: Thalassemia , Prenatal Diagnosis , ARMS , DNA Sequencing<br />
P0486. Quality control of prenatal sonography in detecting<br />
trisomy 18. The value of perinatal autopsy<br />
Z. Szigeti, Z. Csapo, J. Joo, B. Pete, Z. Papp, C. Papp;<br />
First Dept. of Ob/Gyn, Semmelweis University, Budapest, Hungary.<br />
Introduction: Trisomy 18 (Edwards-syndrome) is the second most<br />
common autosomal trisomy. The second-trimester ultrsonographic<br />
examination followed by fetal karyotyping is the most relevant way of<br />
diagnosing this aneuploidy. However, sonographic findings have been<br />
demonstrated to have significant rates of fals-positive and fals-negative<br />
diagnosis. Detailed pathologic examination of aborted fetuses has<br />
important role in the quality control of ultrasonographic diagnosis. This<br />
study was designed to compare the prenatal ultrasound findings and<br />
postmortem pathologic findings of fetuses with trisomy 18.<br />
Materials and Methods: 70 fetuses with trisomy 18 were diagnosed<br />
between <strong>19</strong>90 and 2004. Sonographic and autopsy findings were compared<br />
by organ system and their correlation was assigned to 1 of 3<br />
categories.<br />
Results: There were <strong>16</strong>4 separate major structural abnormalities found<br />
on autopsy. Of them, sonography detected 72 (43.9%). Among major<br />
defects the agreement was more than 75% of all abnormalities<br />
of these systems: central nervous system (80%), abdominal abnormalities<br />
(87.5%) and cystic hygroma (100%). Whereas, the sensitivity<br />
of sonography was lower in these organ systems: cardiac system<br />
(66.6%), facial abnormalities (26.3%), urinary system (27.3%) and extremities<br />
(8.7%). The rate of additional findings at autopsy was 56.1%<br />
and involved mainly 2 organ systems: face (including ear) and extremities<br />
(including hands and feet). Some ultrasound findings (n=15) were<br />
not confirmed at autopsy in our series.<br />
Conclusions: This study confirms that perinatal autopsy provides additional<br />
information in many fetuses with trisomy 18. In addition, exam-<br />
1 2<br />
ining the correlation between sonography and pathologic findings may<br />
indicate potential markers for sonographic screening of trisomy 18.<br />
P0487. Characteristics of pregnancies with cytogenetic<br />
diagnosis of trisomy 21.<br />
K. Keymolen, E. Sleurs, I. Liebaers, C. Staessen;<br />
University hospital, Brussels, Belgium.<br />
Aim of the study: In this study we characterize the pregnancies with<br />
cytogenetic diagnosis of trisomy 21.<br />
Materials and methods: We retrospectively looked at pregnancies in<br />
which trisomy 21 was found in chorionic villus sampling (CVS) or amniocentesis<br />
(AC) between 01.01.2002 and 31.12.2006. Data on maternal<br />
and paternal age ,reason for referral, fetal sex, fetal and parental<br />
karyotype were recorded.<br />
Results: In this 5 year period, 73 prenatal cytogenetic diagnoses of<br />
trisomy 21 were made in our centre. It concerned 44 chorionic villus<br />
biopsies and 29 amniocenteses. In all but one case, there was free<br />
trisomy. Mosaic trisomy was present in 3 cases. Forty-one trisomic<br />
fetuses were male and 32 female. The main reason why cytogenetic<br />
diagnosis was performed, was maternal age (31/73), fetal anomalies<br />
on ultrasound (18/73) and second trimester serum screening (7/73). In<br />
13 pregnancies there were 2 different reasons for referral.<br />
The mean maternal age was 36 years, the mean paternal age 37.1<br />
years.<br />
For 53 parents, a karyotype was performed, being normal for 52 and<br />
showing a translocation for 1.<br />
Discussion: Trisomy 21 is the most common chromosomal anomaly<br />
encountered in CVS or AC. Despite the small sample of this study, the<br />
experience in our centre confirms the common knowledge that it occurs<br />
more frequently in older parents and that in more than half of the<br />
cases there is an anomaly on ultrasound and/or biochemistry. For the<br />
majority of the pregnancies for which follow-up was available, termination<br />
of pregnancy was performed<br />
P0488. Prenatal diagnosis of a marker chromosome derived<br />
from chromosome 3 in a fetus with growth retardation and<br />
microcephaly- a case report<br />
M. I. Srebniak, P. dos Santos, P. Noomen, D. Halley, R. van de Graaf, L. Govaerts,<br />
R. Galjaard, D. Van Opstal;<br />
Erasmus Medical Center, Rotterdam, The Netherlands.<br />
We present a rare prenatal case of an “incomplete” trisomy 3 rescue<br />
which resulted in an extra chromosome 3-derived marker chromosome<br />
in the foetus.<br />
The patient was referred for prenatal cytogenetic diagnosis in chorionic<br />
villi because of advanced maternal age and a growth discrepancy<br />
between both foetuses in her twin pregnancy, with foetus II being too<br />
small for the gestational age.<br />
Whereas foetus I had a normal male karyotype, STC-villi of foetus II<br />
showed 100% trisomy 3 and in LTC-villi an extra marker chromosome,<br />
derived from chromosome 3, was found in all analysed cells. In order<br />
to exclude confined placental mosaicism follow-up investigations in<br />
amniotic fluid cells were performed which showed the marker chromosome<br />
to be present in 100% of the cells. Parental karyotypes were<br />
normal.<br />
FISH- and DNA-studies that were performed in order to characterize<br />
the marker chromosome and to elucidate the mechanism of formation,<br />
respectively, as well as the clinical data of the foetus will be presented.<br />
P0489. The incidence of prenatally diagnosed Turner syndrome<br />
and their referral indications<br />
M. Akgul 1 , E. Ataman 1 , B. Durmaz 2 , A. Alpman 2 , E. Karaca 2 , O. Cogulu 2 , H.<br />
Akin 1 , C. Gunduz 3 , C. Ozkinay 1 , F. Ozkinay 2 ;<br />
1 Ege University, Faculty of Medicine, Department of Medical <strong>Genetics</strong>, Izmir,<br />
Turkey, 2 Ege University, Faculty of Medicine, Department of Pediatrics, Izmir,<br />
Turkey, 3 Ege University, 3Ege University, Faculty of Medicine, Department of<br />
Medical Biology, Izmir, Turkey.<br />
Turner syndrome occurring in 1/2000-5000 female live births is one of<br />
the most common chromosomal disorder. It is also a common reason<br />
in spontaneous miscarriages with an incidence of 10%. As 99% of embryos<br />
with 45,X karyotype result in spontaneous abortion, only 1% of<br />
Turner syndrome fetuses survive till birth. Increased nuchal translucency,<br />
cystic hygroma, and renal and cardiac defects are typical findings